110 related articles for article (PubMed ID: 15700269)
1. The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes.
Berrieman HK; Smith L; O'Kane SL; Campbell A; Lind MJ; Cawkwell L
Cancer; 2005 Apr; 103(7):1415-9. PubMed ID: 15700269
[TBL] [Abstract][Full Text] [Related]
2. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
3. bcl-2 protein in non-small-cell lung carcinoma.
Pezzella F; Turley H; Kuzu I; Tungekar MF; Dunnill MS; Pierce CB; Harris A; Gatter KC; Mason DY
N Engl J Med; 1993 Sep; 329(10):690-4. PubMed ID: 8393963
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
5. Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma.
Huang CI; Neuberg D; Johnson BE; Wei JY; Christiani DC
Cancer; 2003 Jul; 98(1):135-43. PubMed ID: 12833466
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 protein expression correlates with nodal status in non small cell lung cancer.
Groeger AM; Caputi M; Esposito V; De Luca A; Salat A; Murabito M; Giordano GG; Baldi F; Giordano A; Wolner E
Anticancer Res; 1999; 19(1B):821-4. PubMed ID: 10216499
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 expression as an apoptotic index in non small cell lung carcinomas.
Kalogeraki A; Kozoni V; Zoras O; Tamiolakis D; Panayiotides J; Charakidas A; Chalkiadakis G; Bouros D; Stathopoulos E; Delides GS
In Vivo; 2001; 15(1):53-6. PubMed ID: 11286130
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2 family members in malignant pleural mesothelioma.
O'Kane SL; Pound RJ; Campbell A; Chaudhuri N; Lind MJ; Cawkwell L
Acta Oncol; 2006; 45(4):449-53. PubMed ID: 16760181
[TBL] [Abstract][Full Text] [Related]
10. Frequent high expression of bax pro-apoptotic protein in non-small cell lung cancer.
Caputi M; Groeger AM; Esposito V; De Luca A; Murabito M; Tahir T; Giordano GG; Baldi F; Giordano A; Wolner E
Anticancer Res; 1999; 19(1B):825-7. PubMed ID: 10216500
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
[TBL] [Abstract][Full Text] [Related]
12. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy induced changes in apoptosis and its major regulatory proteins, Bcl-2, Bcl-XL, and Bax, in locally advanced invasive squamous cell carcinoma of the cervix.
Adhya AK; Srinivasan R; Patel FD
Int J Gynecol Pathol; 2006 Jul; 25(3):281-7. PubMed ID: 16810067
[TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
15. [c-Met and HGF expression in non-small-cell lung carcinomas].
Korobko IV; Zinov'eva MV; Allakhverdiev AK; Zborovskaia IB; Svwrdlov ED
Mol Gen Mikrobiol Virusol; 2007; (2):18-21. PubMed ID: 17598453
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
17. Expression of bone morphogenetic proteins in human lung carcinomas.
Langenfeld EM; Bojnowski J; Perone J; Langenfeld J
Ann Thorac Surg; 2005 Sep; 80(3):1028-32. PubMed ID: 16122479
[TBL] [Abstract][Full Text] [Related]
18. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
[TBL] [Abstract][Full Text] [Related]
19. Distinct claudin expression profile in histologic subtypes of lung cancer.
Moldvay J; Jäckel M; Páska C; Soltész I; Schaff Z; Kiss A
Lung Cancer; 2007 Aug; 57(2):159-67. PubMed ID: 17418912
[TBL] [Abstract][Full Text] [Related]
20. [The expression and significance of bcl-2 and bax in each phase of the cell cycle in laryngeal carcinoma].
Chen WL; Guo XF; Quan CS; Luan XY
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):157-61. PubMed ID: 15283295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
